Oxaliplatine

DRUG4 trials

Sponsors

Unidad Integral de Investigación en Oncología S.L., Institut Cancerologie de l'Ouest, Oslo University Hospital, The Lymphoma Academic Research Organisation

Conditions

Metastatic Colorectal CancerPancreatic CancerPancreatic Metastatic CancerPeripheral T Cell LymphomaRelapse/RecurrenceToxicity

Phase 2

1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR.

CompletedNCT00345696

Unidad Integral de Investigación en Oncología S.L.Metastatic Colorectal Cancer

Start: 2006-06-30End: 2011-01-31Updated: 2011-08-24

Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic Cancer

CompletedNCT02143219

Institut Cancerologie de l'OuestPancreatic Metastatic Cancer, Toxicity

Start: 2014-07-31End: 2020-11-25Updated: 2026-04-15

Nordic Pancreatic Cancer Trial (NorPACT) - 1

Active, not recruitingNCT02919787

Oslo University HospitalPancreatic Cancer

Start: 2016-09-30End: 2026-04-30Target: 140Updated: 2024-11-20

Study of Lacutamab in Peripheral T-cell Lymphoma

Active, not recruitingNCT04984837

The Lymphoma Academic Research OrganisationPeripheral T Cell Lymphoma, Relapse/Recurrence

Start: 2021-10-05End: 2028-04-30Updated: 2026-06-04

Related Papers

Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial.

2024-01-15123 citations

Strategies to Develop Anti-KIR Mab Lacutamab in Patients with Peripheral T-Cell Lymphoma: Preliminary Monotherapy Clinical Data and Pre-Clinical Combinability Data

Blood2023-11-023 citations

Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial.

2023-08-0738 citations

Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial.

2023-07-0672 citations

Short-course neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer: A multicenter randomized phase-II trial (NORPACT-1).

Journal of Clinical Oncology2023-06-0743 citations

KILT: A RANDOMIZED NON‐COMPARATIVE PHASE II LYSA STUDY OF LACUTAMAB WITH GEMOX VERSUS GEMOX IN RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA

Hematological Oncology2023-06-011 citations

KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target

Blood2022-06-109 citations

A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial

Therapeutic Advances in Medical Oncology2020-01-0113 citations

A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)

BMC Cancer2018-07-1831 citations

Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) – study protocol for a national multicentre randomized controlled trial

BMC Surgery2017-08-2599 citations